Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
31.08
-0.10 (-0.32%)
May 20, 2026, 11:34 AM CST

SHE:000513 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
25,45927,95030,70428,29227,45632,307
Market Cap Growth
-8.14%-8.97%8.53%3.04%-15.02%-2.56%
Enterprise Value
19,53122,22724,77322,70022,29727,114
Last Close Price
31.1834.4636.9332.8029.1934.71
PE Ratio
14.1513.8114.9014.4814.3818.19
Forward PE
13.0713.4015.8317.2516.3618.28
PS Ratio
2.172.332.602.282.172.68
PB Ratio
1.631.802.061.921.842.26
P/TBV Ratio
1.832.102.302.102.082.56
P/FCF Ratio
9.3810.8712.7511.6514.9854.46
P/OCF Ratio
7.868.8910.318.719.9016.98
PEG Ratio
-1.131.131.131.131.13
EV/Sales Ratio
1.671.852.101.831.772.25
EV/EBITDA Ratio
6.247.018.018.288.7011.58
EV/EBIT Ratio
7.618.469.7711.8111.5414.14
EV/FCF Ratio
7.208.6510.299.3512.1745.71
Debt / Equity Ratio
0.190.200.270.280.240.19
Debt / EBITDA Ratio
0.950.961.281.501.401.14
Debt / FCF Ratio
1.091.191.651.711.984.54
Net Debt / Equity Ratio
-0.45-0.51-0.46-0.49-0.46-0.46
Net Debt / EBITDA Ratio
-2.25-2.48-2.24-2.65-2.69-2.83
Net Debt / FCF Ratio
-2.58-3.06-2.88-2.99-3.77-11.18
Asset Turnover
0.480.500.480.500.540.56
Inventory Turnover
2.332.322.092.332.472.74
Quick Ratio
1.661.991.871.861.971.83
Current Ratio
1.962.232.152.132.302.12
Return on Equity (ROE)
15.06%15.83%15.53%12.78%13.37%13.97%
Return on Assets (ROA)
6.59%6.78%6.40%4.81%5.11%5.58%
Return on Invested Capital (ROIC)
26.68%28.26%26.92%19.70%20.64%25.12%
Return on Capital Employed (ROCE)
15.80%15.70%15.10%11.30%11.10%12.40%
Earnings Yield
7.71%7.24%6.71%6.91%6.95%5.50%
FCF Yield
10.66%9.20%7.85%8.58%6.67%1.84%
Dividend Yield
3.53%4.15%2.98%4.12%5.48%3.75%
Payout Ratio
52.66%51.06%65.03%81.36%83.33%70.81%
Buyback Yield / Dilution
2.19%2.96%1.10%0.56%0.04%0.25%
Total Shareholder Return
5.72%7.11%4.08%4.68%5.52%4.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.